Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

Cardiovascular diseases (CVDs) include atherosclerosis, which is an inflammatory disease of large and medium vessels that leads to atherosclerotic plaque formation. The key factors contributing to the onset and progression of atherosclerosis include the pro-inflammatory cytokines interferon (IFN)α a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aleksandra Antonczyk, Katarzyna Kluzek, Natalia Herbich, Mahdi Eskandarian Boroujeni, Bart Krist, Dorota Wronka, Anna Karlik, Lukasz Przybyl, Adam Plewinski, Joanna Wesoly, Hans A. R. Bluyssen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	interferon regulatory factor signal transducer and activator of transcription interferon Toll-like receptor vascular inflammation in silico docking
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1471182/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Black carp RNF115 restricts IRF3/7-mediated antiviral signaling in innate immunity
by: Yixuan He, et al.
Published: (2025-01-01)

Therapeutic potential of targeting the IRF2/POSTN/Notch1 axis in nucleus pulposus cells for intervertebral disc degeneration
by: Daxue Zhu, et al.
Published: (2025-01-01)

Cellular aspects of immunity involved in the development of atherosclerosis
by: Khalil Khalaf, et al.
Published: (2025-01-01)

TLR10 overexpression modulates immune response in A549 lung epithelial cells challenged with SARS-CoV-2 S and N proteins
by: Špela Knez, et al.
Published: (2025-01-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

Heberferón®’s economic feasibility in patients with high-grade brain tumors without therapeutic options
by: María Margarita Ríos Cabrera, et al.
Published: (2024-07-01)

Molecular mechanism of anti-luteolysis during the maternal recognition of pregnancy in cows
by: Aydın Güzeloğlu

The effect of interferon alpha administration on cytokine levels in sheep
by: Devran Coşkun, et al.
Published: (2020-12-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Contemporary Treatment Practices for Subacute Sclerosing Panencephalitis: A Nationwide Survey Among Adult and Pediatric Neurologists in India
by: Divyani Garg, et al.
Published: (2024-12-01)

Preliminary Diagnosis and Characterization of a Spontaneous Immature Testicular Teratoma in an Interferon Receptor-Deficient Mouse Model
by: ZHAO He, et al.
Published: (2024-12-01)

The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated kinase
by: Chien-Cheng Liu, et al.
Published: (2025-03-01)

Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes
by: Murali Ganesan, et al.
Published: (2025-01-01)

Diagnostic value of interferon-γ release assay in patients with COPD complicated with pulmonary tuberculosis
by: Yanxiao Rong, et al.
Published: (2025-01-01)

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
by: Ryohei Yamamura, et al.
Published: (2025-02-01)

A case of familial systemic sclerosis
by: Shreeja Jha, et al.
Published: (2024-12-01)

Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment
by: Lu Y, et al.
Published: (2025-01-01)

Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants
by: Meriem El Houdi, et al.
Published: (2025-01-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers
by: Binhao Liu, et al.
Published: (2025-02-01)

HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01)

Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Sto&#353;i&#263;-Gruji&#269;i&#263;, et al.
Published: (2001-01-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis.
by: Leslie Pérez Ruiz, et al.
Published: (2007-12-01)

Divergent Effects of <i>Circoviridae</i> Capsid Proteins on Type I Interferon Signaling
by: Anon H. Kosaka, et al.
Published: (2025-01-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Heightened expression of type I interferon signaling genes in CD4+ T cells from acutely HIV-1–infected women is associated with lower viral loads
by: Elina El-Badry, et al.
Published: (2025-01-01)

In silico development of a multi-epitope-based vaccine against Burkholderia cepacia complex using reverse vaccinology
by: Donya Ghorbani, et al.
Published: (2025-01-01)

Species- and strain-specific microbial modulation of interferon, innate immunity, and epithelial barrier in 2D air–liquid interface respiratory epithelial cultures
by: Mian Horvath, et al.
Published: (2025-01-01)

Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE
by: Lihong Huo, et al.
Published: (2025-01-01)

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
by: M. V. Mayevskaya
Published: (2011-06-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

ZBP1 senses Brucella abortus DNA triggering type I interferon signaling pathway and unfolded protein response activation
by: Marco Túlio R. Gomes, et al.
Published: (2025-01-01)

MicroRNA-122 protects against interferon-α-induced hepatic inflammatory response via the Janus kinase–signal transducer and activator of transcription pathway
by: Fanwei Liu, et al.
Published: (2025-01-01)

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)

Delay of innate immune responses following influenza B virus infection affects the development of a robust antibody response in ferrets
by: Thomas Rowe, et al.
Published: (2025-02-01)

Comparative monocyte and T cell responses in DENV-exposed subjects from South-East Asia and DENV-naïve residents in Taiwan
by: Sheng-Hsuan Wang, et al.
Published: (2025-02-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)